Changes in arterial oxygenation and self-reported oxygen use after lung volume reduction surgery

Margaret L. Snyder, Christopher H. Goss, Blazej Neradilek, Nayak L. Polissar, Zab Mosenifar, Robert A Wise, Alfred P. Fishman, Joshua O. Benditt

Research output: Contribution to journalArticle

Abstract

Rationale: Lung volume reduction surgery (LVRS) is inconsistently reported to improve arterial oxygenation in patients with chronic obstructive pulmonary disease. Objectives: We studied the effects of surgery on oxygenation in a large cohort and identified predictors of postoperative oxygenation improvement. Methods: We evaluated oxygenation in 1,078 subjects with chronic obstructive pulmonary disease enrolled in the National Emphysema Treatment Trial after LVRS compared with medical control subjects, including arterial blood gases, use of supplemental oxygen during treadmill walking, and self-reported use of oxygen during rest, exertion, and sleep. Measurements and Main Results: PaO2 breathing room air was equal in medical and surgical subjects at baseline (64.8 vs. 65.0 mm Hg, P = not significant), but lower in medical subjects at 6 months (63.6 vs. 70.0 mm Hg, P <0.001), 12 months (63.9 vs. 68.7 mm Hg, P <0.001), and 24 months (62.4 vs. 68.0 mm Hg, P <0.001). Fewer medical subjects required oxygen for treadmill walking at baseline compared with surgical subjects (46 vs. 53%, P = 0.02). However, more medical subjects requiredoxygenfor this activity at 6 months (49 vs.33%, P <0.001), 12 months (50 vs. 36%, P <0.001), and 24 months (52 vs. 42%, P = 0.02). Self-reported oxygen use was greater in medical than in surgical subjects at 6, 12, and 24 months. Multivariate modeling of preoperative characteristics showed baseline oxygenation status was the best predictor of postoperative oxygenation. Conclusions: LVRS increases PaO2, and decreases treadmill and self-reported use of oxygen for up to 24 months post-procedure. Clinical trial registered with www.clinicaltrials.gov (NCT 00000606).

Original languageEnglish (US)
Pages (from-to)339-345
Number of pages7
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume178
Issue number4
DOIs
StatePublished - Aug 15 2008

Fingerprint

Pneumonectomy
Oxygen
Chronic Obstructive Pulmonary Disease
Walking
Emphysema
Sleep
Respiration
Gases
Air
Clinical Trials

Keywords

  • Emphysema
  • Lung diseases, obstructive
  • Oxygen inhalation therapy

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Changes in arterial oxygenation and self-reported oxygen use after lung volume reduction surgery. / Snyder, Margaret L.; Goss, Christopher H.; Neradilek, Blazej; Polissar, Nayak L.; Mosenifar, Zab; Wise, Robert A; Fishman, Alfred P.; Benditt, Joshua O.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 178, No. 4, 15.08.2008, p. 339-345.

Research output: Contribution to journalArticle

Snyder, Margaret L. ; Goss, Christopher H. ; Neradilek, Blazej ; Polissar, Nayak L. ; Mosenifar, Zab ; Wise, Robert A ; Fishman, Alfred P. ; Benditt, Joshua O. / Changes in arterial oxygenation and self-reported oxygen use after lung volume reduction surgery. In: American Journal of Respiratory and Critical Care Medicine. 2008 ; Vol. 178, No. 4. pp. 339-345.
@article{c1d8853a5c9d4de890023c86cec748fa,
title = "Changes in arterial oxygenation and self-reported oxygen use after lung volume reduction surgery",
abstract = "Rationale: Lung volume reduction surgery (LVRS) is inconsistently reported to improve arterial oxygenation in patients with chronic obstructive pulmonary disease. Objectives: We studied the effects of surgery on oxygenation in a large cohort and identified predictors of postoperative oxygenation improvement. Methods: We evaluated oxygenation in 1,078 subjects with chronic obstructive pulmonary disease enrolled in the National Emphysema Treatment Trial after LVRS compared with medical control subjects, including arterial blood gases, use of supplemental oxygen during treadmill walking, and self-reported use of oxygen during rest, exertion, and sleep. Measurements and Main Results: PaO2 breathing room air was equal in medical and surgical subjects at baseline (64.8 vs. 65.0 mm Hg, P = not significant), but lower in medical subjects at 6 months (63.6 vs. 70.0 mm Hg, P <0.001), 12 months (63.9 vs. 68.7 mm Hg, P <0.001), and 24 months (62.4 vs. 68.0 mm Hg, P <0.001). Fewer medical subjects required oxygen for treadmill walking at baseline compared with surgical subjects (46 vs. 53{\%}, P = 0.02). However, more medical subjects requiredoxygenfor this activity at 6 months (49 vs.33{\%}, P <0.001), 12 months (50 vs. 36{\%}, P <0.001), and 24 months (52 vs. 42{\%}, P = 0.02). Self-reported oxygen use was greater in medical than in surgical subjects at 6, 12, and 24 months. Multivariate modeling of preoperative characteristics showed baseline oxygenation status was the best predictor of postoperative oxygenation. Conclusions: LVRS increases PaO2, and decreases treadmill and self-reported use of oxygen for up to 24 months post-procedure. Clinical trial registered with www.clinicaltrials.gov (NCT 00000606).",
keywords = "Emphysema, Lung diseases, obstructive, Oxygen inhalation therapy",
author = "Snyder, {Margaret L.} and Goss, {Christopher H.} and Blazej Neradilek and Polissar, {Nayak L.} and Zab Mosenifar and Wise, {Robert A} and Fishman, {Alfred P.} and Benditt, {Joshua O.}",
year = "2008",
month = "8",
day = "15",
doi = "10.1164/rccm.200712-1826OC",
language = "English (US)",
volume = "178",
pages = "339--345",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "4",

}

TY - JOUR

T1 - Changes in arterial oxygenation and self-reported oxygen use after lung volume reduction surgery

AU - Snyder, Margaret L.

AU - Goss, Christopher H.

AU - Neradilek, Blazej

AU - Polissar, Nayak L.

AU - Mosenifar, Zab

AU - Wise, Robert A

AU - Fishman, Alfred P.

AU - Benditt, Joshua O.

PY - 2008/8/15

Y1 - 2008/8/15

N2 - Rationale: Lung volume reduction surgery (LVRS) is inconsistently reported to improve arterial oxygenation in patients with chronic obstructive pulmonary disease. Objectives: We studied the effects of surgery on oxygenation in a large cohort and identified predictors of postoperative oxygenation improvement. Methods: We evaluated oxygenation in 1,078 subjects with chronic obstructive pulmonary disease enrolled in the National Emphysema Treatment Trial after LVRS compared with medical control subjects, including arterial blood gases, use of supplemental oxygen during treadmill walking, and self-reported use of oxygen during rest, exertion, and sleep. Measurements and Main Results: PaO2 breathing room air was equal in medical and surgical subjects at baseline (64.8 vs. 65.0 mm Hg, P = not significant), but lower in medical subjects at 6 months (63.6 vs. 70.0 mm Hg, P <0.001), 12 months (63.9 vs. 68.7 mm Hg, P <0.001), and 24 months (62.4 vs. 68.0 mm Hg, P <0.001). Fewer medical subjects required oxygen for treadmill walking at baseline compared with surgical subjects (46 vs. 53%, P = 0.02). However, more medical subjects requiredoxygenfor this activity at 6 months (49 vs.33%, P <0.001), 12 months (50 vs. 36%, P <0.001), and 24 months (52 vs. 42%, P = 0.02). Self-reported oxygen use was greater in medical than in surgical subjects at 6, 12, and 24 months. Multivariate modeling of preoperative characteristics showed baseline oxygenation status was the best predictor of postoperative oxygenation. Conclusions: LVRS increases PaO2, and decreases treadmill and self-reported use of oxygen for up to 24 months post-procedure. Clinical trial registered with www.clinicaltrials.gov (NCT 00000606).

AB - Rationale: Lung volume reduction surgery (LVRS) is inconsistently reported to improve arterial oxygenation in patients with chronic obstructive pulmonary disease. Objectives: We studied the effects of surgery on oxygenation in a large cohort and identified predictors of postoperative oxygenation improvement. Methods: We evaluated oxygenation in 1,078 subjects with chronic obstructive pulmonary disease enrolled in the National Emphysema Treatment Trial after LVRS compared with medical control subjects, including arterial blood gases, use of supplemental oxygen during treadmill walking, and self-reported use of oxygen during rest, exertion, and sleep. Measurements and Main Results: PaO2 breathing room air was equal in medical and surgical subjects at baseline (64.8 vs. 65.0 mm Hg, P = not significant), but lower in medical subjects at 6 months (63.6 vs. 70.0 mm Hg, P <0.001), 12 months (63.9 vs. 68.7 mm Hg, P <0.001), and 24 months (62.4 vs. 68.0 mm Hg, P <0.001). Fewer medical subjects required oxygen for treadmill walking at baseline compared with surgical subjects (46 vs. 53%, P = 0.02). However, more medical subjects requiredoxygenfor this activity at 6 months (49 vs.33%, P <0.001), 12 months (50 vs. 36%, P <0.001), and 24 months (52 vs. 42%, P = 0.02). Self-reported oxygen use was greater in medical than in surgical subjects at 6, 12, and 24 months. Multivariate modeling of preoperative characteristics showed baseline oxygenation status was the best predictor of postoperative oxygenation. Conclusions: LVRS increases PaO2, and decreases treadmill and self-reported use of oxygen for up to 24 months post-procedure. Clinical trial registered with www.clinicaltrials.gov (NCT 00000606).

KW - Emphysema

KW - Lung diseases, obstructive

KW - Oxygen inhalation therapy

UR - http://www.scopus.com/inward/record.url?scp=48949101589&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48949101589&partnerID=8YFLogxK

U2 - 10.1164/rccm.200712-1826OC

DO - 10.1164/rccm.200712-1826OC

M3 - Article

VL - 178

SP - 339

EP - 345

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 4

ER -